Investing
Top Pre-Market Analyst Upgrades (ABMD, ASML, CBG, EMR, LLTC, MATK, NFLX, PEP)
Published:
These are some of the top pre-market analyst upgrades and positive calls which we have seen early this Wednesday morning:
Abiomed (ABMD) Raised to Buy at UBS.
ASML (ASML) Raised to Buy at ING.
CB Richard Ellis (CBG) Raised to Overweight at JPMorgan; Raised to Outperform at JMP.
Emerson Electric (EMR) Cut to Neutral at Goldman Sachs.
Linear TEch (LLTC) Raised to Overweight at Thomas Weisel.
Martek Biosciences (MATK) Started as Buy at Cantor.
Netflix (NFLX) Started as Market Perform at William Blair.
Pepsico (PEP) Raised to Buy at UBS.
JON C. OGG
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
